Healthcare News Options
Novo CEO pressed by Senate to chop rates of weight problems, diabetic issues medicine CEO Lars Fruergaard Jørgensen informed lawmakers the corporation would take into account new talks with insurers with regard to the list rates of Wegovy and copyright whenever they pledge to maintain the medicines on their formularies.The deal should be finished